PD-L1, expressed on either cancer cells or cancer-associated immune cells, binds to its respective immune checkpoint receptor, programmed cell death 1 (PD-1), which induces an inhibitory signal in activated T cells to promote T-cell apoptosis, anergy, and functional exhaustion2. This evidence concerns the gene PDCD1 and cancer.